Physician profile
Frank Dopp
NPI 1841399680
$3,861.54
in general payments reported to CMS, 2019-2025
38 companies · $765 in 2025
The $765 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $117 · 2021: $375 · 2022: $358 · 2023: $896 · 2024: $1,003 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,663.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $357.99 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $277.58 | 2023-2025 | Dupixent |
| Genzyme Corporation | $250.42 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $247.12 | 2023-2024 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $231.74 | 2022-2025 | Glassia, Cuvitru |
| Jazz Pharmaceuticals INC. | $220.11 | 2019-2025 | Xywav |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.90 | 2021-2025 | Ofev, Jascayd |
| Baxter Healthcare | $181.72 | 2023-2025 | Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $173.38 | 2019-2024 | Prolastin-C Liquid |
| Novo Nordisk INC | $119.03 | 2019-2024 | Wegovy |
| Mylan Specialty L.P. | $113.90 | 2020-2024 | Yupelri |
| Astrazeneca Pharmaceuticals Lp | $112.49 | 2019-2025 | Fasenra, Breztri |
| Amgen INC. | $101.91 | 2023-2024 | Tezspire, Tavneos |
| United Therapeutics Corporation | $100.70 | 2023-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Enterprises LLC | $99.78 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Dopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.